Clinical Trial Update: Arcos Revision Stem: Evaluation of Clinical Performance

View source ↗

Summary

Clinical trial entry indicates completion of the Arcos Revision Stem study with results posted on 2025-01-20.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Avascular Necrosis
• Osteoarthritis
• Rheumatoid Arthritis

Drugs mentioned

• Arcos Revision Stem

Snippet

Sponsor: Zimmer Biomet | Conditions: Osteoarthritis, Avascular Necrosis | Status: COMPLETED | Results posted: 2025-01-20